KEAP1/NFE2L2 Mutations Are Associated With a Low Immune Infiltration and Low Expression of DNA Damage Response (DDR) Genes in TCGA NSCLC Cohort. The gene discussed is NFE2L2; the disease is non-small cell lung carcinoma.